Published in Cancer Weekly, May 23rd, 2000
While the incidence and prevalence of the acute leukemias are fairly stable in the major pharmaceutical markets under study (United States, France, Germany, Italy, Spain, United Kingdom, and Japan), variations in treatments and the gradual introduction of new analogues continue to drive a slow but steady growth in the sales of drugs to treat...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.